Synthesis and hydrolysis by cathepsin B of fluorogenic substrates with the general structure benzoyl-X-ARG-MCA containing non-natural basic amino acids at position X.

[1]  L. Juliano,et al.  Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates. , 2000, The Biochemical journal.

[2]  G. Veeneman,et al.  Solution-phase and solid-phase synthesis of novel transition state inhibitors of coagulation enzymes incorporating a piperidinyl moiety. , 1999, Bioorganic & medicinal chemistry letters.

[3]  Y. Imai,et al.  The crystal structure of human cathepsin L complexed with E‐64 , 1997, FEBS letters.

[4]  R. Ménard,et al.  Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. , 1996, Biochemistry.

[5]  B. Posner,et al.  Endosomal proteolysis of internalized proteins , 1996, FEBS letters.

[6]  L. Juliano,et al.  Synthesis of N alpha-protected aminoacyl 7-amino-4-methyl-coumarin amide by phosphorous oxychloride and preparation of specific fluorogenic substrates for papain. , 1996, Peptide research.

[7]  C. P. Huber,et al.  Characterization of the S Subsite Specificity of Cathepsin B (*) , 1995, The Journal of Biological Chemistry.

[8]  C. P. Huber,et al.  Crystal Structures of Recombinant Rat Cathepsin B and a Cathepsin B-Inhibitor Complex , 1995, The Journal of Biological Chemistry.

[9]  P. Bonneau,et al.  Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity. , 1994, The Journal of biological chemistry.

[10]  J. Palmer,et al.  Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. , 1994, Arthritis and rheumatism.

[11]  W. F. Hoffman,et al.  A simple and inexpensive synthesis of 4-(aminomethyl)-L-phenylalanine , 1993 .

[12]  C. P. Huber,et al.  Characterization of cathepsin B specificity by site-directed mutagenesis. Importance of Glu245 in the S2-P2 specificity for arginine and its role in transition state stabilization. , 1993, The Journal of biological chemistry.

[13]  R. Ménard,et al.  Engineering of papain: selective alteration of substrate specificity by site-directed mutagenesis. , 1991, Biochemistry.

[14]  Robert Huber,et al.  The refined 2.15 A X‐ray crystal structure of human liver cathepsin B: the structural basis for its specificity. , 1991, The EMBO journal.

[15]  J. Bozell,et al.  Transition-metal-assisted asymmetric synthesis of amino acid analogs. A new synthesis of optically pure D- and L-pyridylalanines , 1991 .

[16]  C. Acosta,et al.  SYNTHESIS OF cis AND trans-4-AMINOCYCLOHEXYL-D-ALANINE DERIVATIVES AND DETERMINATION OF THEIR STEREOCHEMISTRY , 1991 .

[17]  R. Ménard,et al.  A protein engineering study of the role of aspartate 158 in the catalytic mechanism of papain. , 1990, Biochemistry.

[18]  L. Juliano,et al.  Ionization constants and thermodynamic parameters of histidine and derivatives , 1983 .

[19]  L. Juliano,et al.  Ionization of methyl derivatives of imidazole, histidine, thyreotropin releasing factor, and related compounds. , 1976, Journal of the American Chemical Society.

[20]  L. Juliano,et al.  Conformation of angiotensin II in aqueous solution. Titration of several peptide analogs and homologs. , 1974, Biochemistry.

[21]  G. N. Wilkinson Statistical estimations in enzyme kinetics. , 1961, The Biochemical journal.

[22]  M. Mcgrath The lysosomal cysteine proteases. , 1999, Annual review of biophysics and biomolecular structure.

[23]  N. Rawlings,et al.  Proteinases 1: lysosomal cysteine proteinases. , 1995, Protein profile.

[24]  Bonnie F. Sloane,et al.  Chapter 12 – Regulation of Lysosomal Endopeptidases in Malignant Neoplasia , 1994 .

[25]  R. Ménard,et al.  Catalytic mechanism in papain family of cysteine peptidases. , 1994, Methods in enzymology.

[26]  A. Barrett [57] Cystatin, the egg white inhibitor of cysteine proteinases , 1981 .

[27]  Alan J. Barrett,et al.  [41] Cathepsin B, cathepsin H, and cathepsin L , 1981 .